Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates

Virulence

Volumn 5, Issue 2, 2014, Pages 326-330

  Thomas, Renjan ^a   Hamat, Rukman Awang ^a   Neela, Vasanthakumari ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Gram negative; Hydrolytic enzymes; Nosocomial pathogen; Pathogenicity; Stenotrophomonas maltophilia; Virulence factors

Indexed keywords

DEOXYRIBONUCLEASE; FLUORESCEIN; GELATINASE; GENOMIC DNA; HEPARIN LYASE; HYALURONIDASE; MELANIN; PHOSPHOLIPASE; PROTEINASE;

BACTEREMIA; BACTERIUM ISOLATE; BIOFILM; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; IMMUNOCOMPROMISED PATIENT; LETTER; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; STENOTROPHOMONAS MALTOPHILIA;

GRAM-NEGATIVE; HYDROLYTIC ENZYMES; NOSOCOMIAL PATHOGEN; PATHOGENICITY; STENOTROPHOMONAS MALTOPHILIA; VIRULENCE FACTORS;

BACTERIAL PROTEINS; CROSS INFECTION; ENVIRONMENTAL MICROBIOLOGY; ENZYMES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; STENOTROPHOMONAS MALTOPHILIA; VIRULENCE FACTORS;

EID: 84897863595     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.27724     Document Type: Letter

References (46)

1. Looney WJ, Narita M, Mühlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009; 9:312-23; PMID:19393961; http://dx.doi. org/10.1016/S1473-3099(09)70083-0
2. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 2007; 45:1602-9; PMID:18190323; http://dx.doi. org/10.1086/522998
3. Rolston KV, Kontoyiannis DP, Yadegarynia D, Raad II. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis 2005; 51:215-8; PMID:15766609; http://dx.doi. org/10.1016/j.diagmicrobio.2004.11.002
4. Andrews JM; BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008; 62:256-78; PMID:18474513; http://dx.doi. org/10.1093/jac/dkn194
5. Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007; 26:229-37; PMID:17334747; http://dx.doi.org/10.1007/ s10096-007-0279-3
6. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11:57-80; PMID:9457429
7. Looney WJ. Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br J Biomed Sci 2005; 62:145-54, quiz 1, 154; PMID:16196464
8. Senol E. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen. J Hosp Infect 2004; 57:1-7; PMID:15142709; http:// dx.doi.org/10.1016/j.jhin.2004.01.033
9. Araoka H, Baba M, Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis 2010; 29:605-8; PMID:20177726; http://dx.doi.org/10.1007/ s10096-010-0882-6
10. Edberg S, Gallo P, Kontnick C. Analysis of the virulence characteristics of bacteria isolated from bottled, water cooler, and tap water. Microb Ecol Health Dis 1996; 9:67-77; http://dx.doi. org/10.3109/08910609609166445
11. Pavlov D, de Wet CM, Grabow WO, Ehlers MM. Potentially pathogenic features of heterotrophic plate count bacteria isolated from treated and untreated drinking water. Int J Food Microbiol 2004; 92:275-87; PMID:15145586; http://dx.doi.org/10.1016/j. ijfoodmicro.2003.08.018
12. De Vidipó LA, De Marques EA, Puchelle E, Plotkowski MC. Stenotrophomonas maltophilia interaction with human epithelial respiratory cells in vitro. Microbiol Immunol 2001; 45:563-9; PMID:11592630; http:// dx.doi.org/10.1111/j.1348-0421.2001.tb01287.x
13. Pompilio A, Crocetta V, Confalone P, Nicoletti M, Petrucca A, Guarnieri S, Fiscarelli E, Savini V, Piccolomini R, Di Bonaventura G. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol 2010; 10:102; PMID:20374629; http://dx.doi. org/10.1186/1471-2180-10-102
14. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 2008; 9:R74; PMID:18419807; http:// dx.doi.org/10.1186/gb-2008-9-4-r74
15. Janda JM, Bottone EJ. Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool. J Clin Microbiol 1981; 14:55-60; PMID:6790569
16. Neela V, Thomas R, Rankouhi SZ, Karunanidhi A, Shueh CS, Hamat RA, van Belkum A. Modified DNase tube test to detect DNase activity in Stenotrophomonas maltophilia. J Med Microbiol 2012; 61:1792-4; PMID:22956752; http://dx.doi. org/10.1099/jmm.0.049403-0
17. McDADE JJ, Weaver RH. Rapid methods for the detection of gelatin hydrolysis. J Bacteriol 1959; 77:60-4; PMID:13620650
18. Frazier WC. A Method for the Detection of Changes in Gelatin Due to Bacteria Two Plates. J Infect Dis 1926; 39:302-9; http://dx.doi.org/10.1093/ infdis/39.4.302
19. Travassos LH, Pinheiro MN, Coelho FS, Sampaio JL, Merquior VL, Marques EA. Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro, Brazil. J Appl Microbiol 2004; 96:1143-50; PMID:15078532; http://dx.doi.org/10.1111/j.1365-2672.2004.02248.x
20. Riley T. A simple method for detecting heparinase-producing bacteria. Lett Appl Microbiol 1987; 4:21-3; http://dx.doi.org/10.1111/j.1472-765X.1987. tb01573.x
21. Smith RF, Willett NP. Rapid plate method for screening hyaluronidase and chondroitin sulfataseproducing microorganisms. Appl Microbiol 1968; 16:1434-6; PMID:4877667
22. Nord CE, Sjöberg L, Wadström T, Wretlind B. Characterization of three Aeromonas and nine pseudomonas species by extracellular enzymes and haemolysins. Med Microbiol Immunol 1975; 161:79-87; PMID:1170482; http://dx.doi.org/10.1007/ BF02121748
23. Rollof J, Hedström SA, Nilsson-Ehle P. Lipolytic activity of Staphylococcus aureus strains from disseminated and localized infections. Acta Pathol Microbiol Immunol Scand B 1987; 95:109-13; PMID:3591310
24. Burke V, Robinson JO, Richardson CJ, Bundell CS. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis. Pathology 1991; 23:145-8; PMID:1745565; http://dx.doi. org/10.3109/00313029109060814
25. Wang G, Aazaz A, Peng Z, Shen P. Cloning and overexpression of a tyrosinase gene mel from Pseudomonas maltophila. FEMS Microbiol Lett 2000; 185:23-7; PMID:10731602; http://dx.doi. org/10.1111/j.1574-6968.2000.tb09035.x
26. King EO, Ward MK, Raney DE. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med 1954; 44:301-7; PMID:13184240
27. MacFaddin J. Media for the isolation-cultivationidentification-maintenance of medical bacteria, vol. 1 Williams & Wilkins. Baltimore, MD 1985.
28. Liaw S-J, Lee Y-L, Hsueh P-R. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents 2010; 35:126-30; PMID:19926255; http://dx.doi.org/10.1016/j. ijantimicag.2009.09.015
29. Passerini de Rossi B, Calenda M, Vay C, Franco M. Biofilm formation by Stenotrophomonas maltophilia isolates from device-associated nosocomial infections. Rev Argent Microbiol 2007; 39:204-12; PMID:18390153
30. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22:996-1006; PMID:3905855
31. Stepanović S, Cirković I, Ranin L, Svabić-Vlahović M. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett Appl Microbiol 2004; 38:428-32; PMID:15059216; http://dx.doi.org/10.1111/j.1472-765X.2004.01513.x
32. Rashid MH, Kornberg A. Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2000; 97:4885-90; PMID:10758151; http://dx.doi.org/10.1073/pnas.060030097
33. Bottone EJ, Reitano M, Janda JM, Troy K, Cuttner J. Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum. J Clin Microbiol 1986; 24:995-7; PMID:3537006
34. O'Brien M, Davis GH. Enzymatic profile of Pseudomonas maltophilia. J Clin Microbiol 1982; 16:417-21; PMID:6813350
35. Travis J, Potempa J, Maeda H. Are bacterial proteinases pathogenic factors? Trends Microbiol 1995; 3:405-7; PMID:8564361; http://dx.doi. org/10.1016/S0966-842X(00)88988-X
36. Stehr F, Kretschmar M, Kröger C, Hube B, Schäfer W. Microbial lipases as virulence factors. J Mol Catal, B Enzym 2003; 22:347-55; http://dx.doi. org/10.1016/S1381-1177(03)00049-3
37. Miskin JE, Farrell AM, Cunliffe WJ, Holland KT. Propionibacterium acnes, a resident of lipidrich human skin, produces a 33 kDa extracellular lipase encoded by gehA. Microbiology 1997; 143:1745-55; PMID:9168624; http://dx.doi. org/10.1099/00221287-143-5-1745
38. Cheng Q, Yu MC, Reeves AR, Salyers AA. Identification and characterization of a Bacteroides gene, csuF, which encodes an outer membrane protein that is essential for growth on chondroitin sulfate. J Bacteriol 1995; 177:3721-7; PMID:7601836
39. Vazquez-Boland JA, Kocks C, Dramsi S, Ohayon H, Geoffroy C, Mengaud J, Cossart P. Nucleotide sequence of the lecithinase operon of Listeria monocytogenes and possible role of lecithinase in cell-to-cell spread. Infect Immun 1992; 60:219-30; PMID:1309513
40. Duran-Reynals F. Studies on a Certain Spreading Factor Existing in Bacteria and Its Significance for Bacterial Invasiveness. J Exp Med 1933; 58:161-81; PMID:19870187; http://dx.doi.org/10.1084/ jem.58.2.161
41. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005; 52:113-22; PMID:15964499; http:// dx.doi.org/10.1016/j.diagmicrobio.2005.02.007
42. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-5; PMID:15001782; http://dx.doi. org/10.1126/science.1092385
43. Fox JB, Holtman DF. Effect of anaerobiosis on staphylococcal nuclease production. J Bacteriol 1968; 95:1548-50; PMID:5650065
44. Rahmoune H, Lamblin G, Lafitte JJ, Galabert C, Filliat M, Roussel P. Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis. Am J Respir Cell Mol Biol 1991; 5:315-20; PMID:1910815; http://dx.doi.org/10.1165/ ajrcmb/5.4.315
45. Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol 2003; 5:203-23; PMID:12675679; http://dx.doi. org/10.1046/j.1462-5814.2003.00268.x
46. Liaw SJ, Lee YL, Hsueh PR. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents 2010; 35:126-30; PMID:19926255; http://dx.doi.org/10.1016/j. ijantimicag.2009.09.015